Review



genome wide crispr cas9 loss  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Addgene inc genome wide crispr cas9 loss
    Genome Wide Crispr Cas9 Loss, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 95 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/genome+wide+crispr+cas9+loss/Human+Genome-wide+CRISPRi-v2+Libraries+(Pooled+Libraries+%2383969%2C+%231000000090)/pm41392282-68-7-23
    Average 95 stars, based on 95 article reviews
    genome wide crispr cas9 loss - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Genome Wide:

    Article Title: Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair.
    Article Snippet: .. 182 Genome-Wide CRISPR-Cas9 Knockout Screening 183 A genome-wide CRISPR-Cas9 loss-of-function screen was 184 performed using the human GeCKO v2 pooled sgRNA library 185 (Addgene, #52961), which encodes both sgRNAs and Cas9 in a 186 single lentiviral construct. ..

    CRISPR:

    Article Title: Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair.
    Article Snippet: .. 182 Genome-Wide CRISPR-Cas9 Knockout Screening 183 A genome-wide CRISPR-Cas9 loss-of-function screen was 184 performed using the human GeCKO v2 pooled sgRNA library 185 (Addgene, #52961), which encodes both sgRNAs and Cas9 in a 186 single lentiviral construct. ..

    Knock-Out:

    Article Title: Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair.
    Article Snippet: .. 182 Genome-Wide CRISPR-Cas9 Knockout Screening 183 A genome-wide CRISPR-Cas9 loss-of-function screen was 184 performed using the human GeCKO v2 pooled sgRNA library 185 (Addgene, #52961), which encodes both sgRNAs and Cas9 in a 186 single lentiviral construct. ..

    Construct:

    Article Title: Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair.
    Article Snippet: .. 182 Genome-Wide CRISPR-Cas9 Knockout Screening 183 A genome-wide CRISPR-Cas9 loss-of-function screen was 184 performed using the human GeCKO v2 pooled sgRNA library 185 (Addgene, #52961), which encodes both sgRNAs and Cas9 in a 186 single lentiviral construct. ..



    Similar Products

    genome wide crispr cas9 loss  (Addgene inc)
    95
    Addgene inc genome wide crispr cas9 loss
    Genome Wide Crispr Cas9 Loss, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/genome+wide+crispr+cas9+loss/Human+Genome-wide+CRISPRi-v2+Libraries+(Pooled+Libraries+%2383969%2C+%231000000090)/pm41392282-68-7-23
    Average 95 stars, based on 1 article reviews
    genome wide crispr cas9 loss - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    data analysis whole genome crispr cas9 loss  (Addgene inc)
    95
    Addgene inc data analysis whole genome crispr cas9 loss
    Data Analysis Whole Genome Crispr Cas9 Loss, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/genome+wide+crispr+cas9+loss/Human+Genome-wide+CRISPRi-v2+Libraries+(Pooled+Libraries+%2383969%2C+%231000000090)/pm32499560-402-3-29
    Average 95 stars, based on 1 article reviews
    data analysis whole genome crispr cas9 loss - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier

    Image Search Results